Вирусы и эпидемии в истории мира. Прошлое, настоящее и будущее - читать онлайн книгу. Автор: Майкл Олдстоун cтр.№ 125

1. Henderson, D. A. “Smallpox Eradication.” In Microbe Hunters – Then and Now, edited by H. Koprowski and M. B. A. Oldstone, 39–44. Bloomington, IL: Medi-Ed Press, 1996.

2. Hopkins, D. Princes and Peasants: Smallpox in History. Chicago: University of Chicago Press, 1983.

3. Thomas, H. Conquest: Montezuma, Cortés, and the Fall of Old Mexico. New York: Simon & Schuster, 1993.

4. McNeill, W. H. Plagues and Peoples. New York: Anchor Books, 1976.

5. Malone, D. Jefferson the President: First Term 1801–1805. Boston: Little, Brown, 1970.

6. Gibson, J. E. Dr. Bodo Otto and the Medical Background of the American Revolution. Springfield, IL: Charles C. Thomas, 1937.

7. Paul, J. R. A History of Poliomyelitis. New Haven, CT: Yale University Press, 1971.

8. Gard, S. Presentation speech for the Nobel Prize in Physiology and Medicine. Stockholm, Sweden, 1954.

9. Oldstone, M. B. A., and M. R. Oldstone. Ebola’s Curse: 2013–2016 Outbreak in West Africa. London: Academic Press, 2017.

1. Medawar, P. B., and J. S. Medawar. Aristotle to Zoos. Cambridge, MA: Harvard University Press, 1983.

2. Hirsch, M. S., and J. Curran. “Human Immunodeficiency Virus.” In Fields Virology, edited by B. N. Fields, 1953–76. New York: Raven Press, 1990.

3. Sattentau, Q. J., A. G. Dalgleish, R. A. Weiss, and P. C. Beverley. “Epitopes of the CD4 Antigen and HIV Infection.” Science 234 (1986): 1120–23.

4. Naniche, D., G. Varior-Krishman, F. Cervoni, T. F. Wild, B. Rossi, C. Rabourdin-Combe, and D. Gerlier. “Human Membrane Cofactor Protein (CD46) Acts as a Cellular Receptor for Measles Virus.” Journal of Virology 67 (1993): 6025–32.

5. Dorig, R. E., A. Marcel, A. Chopra, and C. D. Richardson. “The Human CD46 Molecule Is a Receptor for Measles Virus (Edmonston Strain).” Cell 75 (1993): 295–305.

6. Manchester, M., M. K. Liszewski, J. P. Atkinson, and M. B. A. Oldstone. “Multiple Isoforms of CD46 (Membrane Cofactor Protein) Serve as Receptors for Measles Virus.” Proceedings of the National Academy of Sciences USA 91 (1994): 2161–65.

7. Johnstone, R., B. E. Loveland, and I. F. McKenzie. “Identification and Quantification of Complement Regulator CD46 on Normal Human Tissues.” Immunology 79 (1993): 341–47.

8. Tatsuo, H., N. Ono, K. Tanaka, and Y. Yanagi. “SLAM (CDw150) Is a Cellular Receptor for Measles Virus.” Nature 406 (2000): 893–97.

9. Yanagi, Y., M. Takeda, S. Ohno, and T. Hashiguchi. “Measles Virus Receptors.” Current Topics in Microbiology and Immunology 329 (2009): 13–30.

10. Oldstone, M. B. A. “Virus Neutralization and Virus-Induced Immune Complex Disease: Virus – Antibody Union Resulting in Immunoprotection or Immunologic Injury – Two Sides of the Same Coin.” In Progress in Medical Virology, Vol. 19, edited by J. L. Melnick, 84–119. Basel, Switzerland: Karger, 1975.

11. Oldstone, M. B. A. “Molecular Anatomy of Viral Disease.” Neurology 37 (1987): 453–60.

12. Oldstone, M. B. A. “Viruses and Diseases of the Twenty-first Century.” American Journal of Pathology 143 (1993): 1241–49.

13. Braciale, T. J., Y. S. Hahn, and D. R. Burton. “The Adoptive Immune Response to Viruses.” In Fields Virology, 5th ed., edited by D. Knipe and P. Howley, 275–326. Philadelphia: Lippincott Williams & Wilkins, 2007.

14. Ivanovski, D. I. “Ueber die Mosaikkrankheit der Tabakspflanze.” Zentralblatt für Bakteriologie Parasitenkunde und Infektionskrankheiten II 5 (1899): 250–54.

15. Beijerinck, M. W. “Bemerkung zu dem Aufsatz von Herrn Iwanowsky uber die Mosaikkrankheit der Tabakspflanze.” Zentralblatt für Bakteriologie Parasitenkunde und Infektionskrankheiten I 5 (1899): 310–11.

16. Loeffler, F., and P. Frosch. “Berichte der Kommission zur Erforschung der Maul und Klauenseuche bei dem Institut fur Infektionskrankheiten in Berlin.” Zentralblatt für Bakteriologie Parasitenkunde und Infektionskrankheiten I 23 (1898): 371–91.

1. Braciale, T. J., Y. S. Hahn, and D. R. Burton. “The Adoptive Immune Response to Viruses.” In Fields Virology, 5th ed., edited by D. Knipe and P. Howley, 275–326. Philadelphia: Lippincott Williams & Wilkins, 2007.

2. Biron, C. A., and G. Sen. “Innate Responses to Viral Infections.” In Fields Virology, 5th ed., edited by D. Knipe and P. Howley, 249–278. Philadelphia: Lippincott Williams & Wilkins, 2007.

3. Barber, D. L., E. J. Wherry, D. Masopust, B. Zhu, J. P. Allison, A. H. Sharpe, G. J. Freeman, and R. Ahmed. “Restoring Function in Exhausted CD8 T Cells During Chronic Viral Infection.” Nature 439 (2006): 682–87.

4. Brooks, D. G., M. J. Trifilo, K. H. Edelmann, L. Teyton, D. B. McGavern, and M. B. A. Oldstone. “Interleukin– 10 Determines Viral Clearance or Persistence In Vivo.” Nature Medicine 12 (2006): 1301–9.

5. Wherry, E. J. “T Cell Exhaustion.” Nature Immunology 12 (2011): 492–99.

6. June, C. H., and M. Sadelain. “Chimeric Antigen Receptor Therapy.” New England Journal of Medicine 379 (2018): 64–73.

7. Kaiser, J., and J. Couzin-Frankel. “Cancer Immunotherapy Sweeps Nobel for Medicine.” Science 362 (2018): 13.

8. Hoos, A. “Development of Immuno-oncology Drugs – From CTLA4 to PD1 to the Next Generation.” Nature Reviews Drug Discovery 15 (2016): 235–47.

9. Koszinowski, U. H., S. Jonjic, and M. J. Reddehase. “The Role of CD4 and CD8 T Cells in Viral Infections.” Current Opinion in Immunology 3 (1991): 471–75.

10. Doherty, P. C., S. Hou, and R. A. Tripp. “CD8+ T– Cell Memory to Viruses.” Current Opinion in Immunology 6 (1994): 545–52.

11. Wherry, E. J., and R. Ahmed. “Memory CD8+ T Cell Differentiation During Viral Infection.” Journal of Virology 78 (2004): 5535–45.

12. Ahmed, R., and D. Gray. “Immunologic Memory and Protective Immunity: Understanding Their Relationship.” Science 272 (1996): 54–60.

13. Matloubian, M., R. J. Concepcion, and R. Ahmed. “CD4+ T Cells Are Required to Sustain CD8+ Cytotoxic T– Cell Responses During Chronic Viral Infection.” Journal of Virology 68 (1994): 8056–63.

14. Tishon, A., H. Lewicki, G. Rall, M. von Herrath, and M. B. A. Oldstone. “An Essential Role for Type I Interferon-Gamma in Terminating Persistent Viral Infection.” Virology 212 (1995): 244–50.